Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

1,775.00p
   
  • Change Today:
    -65.00p
  • 52 Week High: 3,650.00
  • 52 Week Low: 1,752.50
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 8,927
  • Market Cap: £92.74m
  • Beta: 0.39

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-21 10.93 8.12 129.22p 30.7 n/a -7% 105.00p 2.6%
30-Jun-22 11.72 9.28 147.32p 23.4 1.7 +14% 126.00p 3.7%
30-Jun-23 12.82 10.13 160.63p 24.0 2.7 +9% 152.00p 3.9%
30-Jun-24 13.61 10.60 155.12p 28.4 n/a -3% 155.00p 3.5%
30-Jun-25 13.12 10.10 145.27p 18.9 n/a -6% 150.00p 5.5%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-26 12.50 9.40 136.10p 13.0 n/a -6% 150.00p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 30.72 18.93 25.08 0.49

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Bioventix Market Data

Currency UK Pounds
Share Price 1,775.00p
Change Today -65.00p
% Change -3.53 %
52 Week High 3,650.00
52 Week Low 1,752.50
Volume 8,927
Shares Issued 5.22m
Market Cap £92.74m
Beta 0.39

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 06-Nov-25 10-Apr-25
Paid 21-Nov-25 25-Apr-25
Amount 80.00p 70.00p

Trades for 10-Dec-2025

Time Volume / Share Price
15:25 2,340 @ 1,784.00p
16:22 70 @ 1,765.00p
16:09 25 @ 1,783.00p
15:56 6 @ 1,800.00p
15:56 110 @ 1,762.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page